NFKB1 and cancer: Dysfunction of NFκB signaling and ZFs is associated with metabolic syndromes, inflammation, cancer, and age-related diseases (Beishline and Azizkhan-Clifford, 2015; Bu et al., 2021; Hosea et al., 2023).